‘Bio Korea 2020’ From diagnosis to treatment of COVID-19… Arrange a special session.

20-05-14

'BIO KOREA 2020' hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do will be held online from the 18th to the 23rd. This year, we prepared a special session on the theme of vaccine trends for the novel coronavirus infection (Corona 19), which is spreading around the world.

Due to the spread of the novel coronavirus infection (Corona 19), the entire event will be held online (www.biokorea.org). To this end, KISA has built a system that can be operated stably even if 4,000 people access it at the same time.

Kwon Deok-cheol, director of the Korea Health Industry Development Institute, said at a press conference held at the Korea Chamber of Commerce and Industry in Seoul on the 14th, "At this Bio Korea event, we prepared a special session to see various cases such as COVID-19 diagnosis, domestic and foreign treatment and vaccine development trends."

The COVID-19 special session begins on the 18th with a keynote speech by Jerome Kim, secretary general of the International Vaccine Institute (IVI), and continues until the 21st. Conferences on COVID-19 diagnostic kits, treatment/vaccine development, and cases of international cooperation will be held on a daily basis.

On the 19th and 20th, panel discussions by industry experts will be held on key issues such as the development and export of COVID-19 diagnostic kits and the trend of treatment development.

On the 20th, a conference on the development status of COVID-19 treatment being developed worldwide will be held. Along with the introduction of major treatment candidates, news on the current status of COVID-19 treatment development by domestic companies will also be provided separately.

After Bridge Bio CEO Lee Jung-kyu and Korea Research Institute of Chemical Technology (KRICT) doctor Mi-Hyeon Kim introduced global development and strategies, Kim Seung-taek, director of Institut Pasteur Korea, Song Soon-wook, vice president of SCM Life Science, Cho Dae-woong, Cellivery CEO, and Olix CEO Lee Dong-ki presented the development status of domestic companies. Is expected.

On the 21st, examples of ongoing international cooperation for the development of treatments and vaccines will be introduced.

In addition to the COVID-19 special session, this online conference will consist of a total of 24 sessions on Alzheimer's disease, antibodies, and regenerative medicine, with around 90 domestic and foreign speakers participating.

In addition to conferences attended by experts, a special COVID-19 hall will be operated through a virtual exhibition hall.

The COVID-19 Special Pavilion is operated together within the Innovative Pharmaceutical Company Pavilion. According to the diagnosis protocol, from COVID-19 diagnosis to sample collection and reading, patients are provided with relevant information so that they can respond according to serious injuries, and in this process, about 50 related companies, such as diagnostic equipment and medical equipment, are introduced.

Domestic COVID-19 treatment and vaccine development companies and pipelines will also be introduced through a special COVID-19 hall within the innovative pharmaceutical company hall.

Employment and start-up programs are also conducted through the job fair held during the event.

The job fair consists of a recruitment briefing session, a special lecture on CEO life, a startup academy, and a job talk concert.

About 30 companies, including GC Green Cross, Dong-A Pharmaceutical, SK Chemicals, Osstem Implant, and Tium Bio, will participate in the online recruitment briefing and plan to hire about 150 people. In addition, special lectures on CEO life, startup academy, and job talk concert were prepared.

In addition, it provides business meetings and investment attraction opportunities for companies through business forums and investment fairs.

The business forum is conducted in real time through a video meeting platform. Currently, 1,600 meetings have been confirmed and will be held 24 hours a day during the event.

Invest Fair is an online company introduction (IR) by 24 companies in 8 fields. Celltrion, Solgent, SCM Life Science, ImmuneMed, Biosolution, Genome & Company, HLB, ABL Bio, GC Green Cross Cell, i-Sense, Tium Bio, Neuroventi, Ensol Bioscience, Rgnomics, etc. will participate. .

Director Kwon said, "As this Bio Korea 2020 is held online, it is expected that 500 companies from 30 countries will participate."